Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway-Reference-Cited by-同舟云学术

Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway

Published:2018-10-09 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Ke Xiao‑Xue¹,Pang Yi¹,Chen Kuijun²,Zhang Dunke¹,Wang Feng¹,Zhu Shunqin¹,Mao Jingxin¹,Hu Xiaosong¹,Zhang Guanghui¹,Cui Hongjuan¹

Affiliation:

1. Cell Biology Laboratory, State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400716, P.R. China

2. Department 6 of The Research Institute of Surgery, State Key Laboratory of Trauma, Burns and Combined Injury, Daping Hospital, Army Medical University, Chongqing 400042, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minnelide exhibits antileukemic activity by targeting the Ars2/miR-190a-3p axis;Phytomedicine;2024-07

2. Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer;Cancers;2023-05-22

3. Arsenic resistance protein 2 and microRNA biogenesis: Biological implications in cancer development;Pharmacology & Therapeutics;2023-04

4. Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell Viability;International Journal of Molecular Sciences;2023-03-17

5. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma;Life Sciences;2022-02